腺苷蛋氨酸(adenosymethionine,SAM)是人体中重要的代谢中间体,在医疗上被广泛应用于治疗肝炎,抑郁症以及关节炎等疾病。酶法进行腺苷蛋氨酸的生产具有良好的工业前景。将来源于酿酒酵母BY4741中的腺苷蛋氨酸合酶基因(sam2)进行密码子优化后,与pET-28a(+)和pET-3b(+)进行连接获得重组质粒pET-28a(+)-sam2和pET-3b(+)-sam2,分别实现其在E. coli BL21(DE3)和E. coli Rosetta(DE3)中的异源表达,结果表明,重组菌E. coli BL21/ pET-28a(+)-sam2的SAM酶活较高,达到0.184 U/mL。对该重组菌株进行发酵条件优化,在最优条件下,SAM合酶最高酶活为0.245 U/mL,比优化前提高34%。
毛职医
,
谈新苑
,
曹蓉
,
张晓娟
,
付静
,
徐建国
,
徐国强
,
张晓梅
,
许正宏
. 大肠杆菌表达腺苷蛋氨酸合酶及产酶条件优化[J]. 食品与发酵工业, 2020
, 46(10)
: 8
-13
.
DOI: 10.13995/j.cnki.11-1802/ts.023219
Adenosylmethionine (SAM) plays a vital role in the organisms’ metabolic activity as an important intermediate metabolite and has been widely used in pharmaceutical industry involving the therapies for liver, nervous systems, osteoarthritis and so on. Thus, production of SAM by enzyme transformation process exhibits potential industrial prospects. Codon optimization of the adenosylmethionine synthase gene sam2 derived from S. cerevisiae BY4741 was performed, and the gene was ligated to pET-28a(+) and pET-3b(+), resulting in recombinant plasmids pET-28a(+)-sam2 and pET-3b(+)-sam2, respectively, and was heterologous expressed in E. coli BL21(DE3) and E. coli Rosseta (DE3) respectively. Results showed that the recombinant strain E. coli BL21/ pET28a(+)-sam2 exhibited higher enzymatic activity up to 0.184 U/mL. Thus, the recombinant strain E. coli BL21/ pET-28a(+)-sam2 was chosen for the optimization of fermentation condition to further improve the enzymatic activity. Under optimal conditions, the enzyme activity of the recombinant adenosylmethionine synthase reached 0.245 U/mL, which was 34% higher than that before optimization.
[1] MATO J M,ALVAREZ L,ORTIZ P,et al.S-adenosylmethionine synthesis:Molecular mechanisms and clinical implications[J].Pharmacology Therapeutics,1997,73(3):265-280.
[2] ZHAO Weijun,SHI Feng,HANG Baojian,et al.The improvement of SAM accumulation by integrating the endogenous methionine adenosyltransferase gene SAM2 in genome of the industrial Saccharomyces cerevisiae strain[J].Applied Biochemistry and Biotechnology,2016,178(6):1 263-1 272.
[3] CARMEN GATCÍA-RUIZ,MORALES A,COLELL A,et al.Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes[J].Hepatology,1995,21(1):207-214.
[4] CANTONI G L.The nature of the active methyl donor formed enzymatically from L-methionine and adenosinetriphosphate[J].Journal of the American Chemical Society,1952,74(11):2 942-2 943.
[5] 张巍巍,刘云顺,王颖,等.S-腺苷蛋氨酸在肝病患者中抗抑郁作用的研究进展[J].现代生物医学进展,2015,15(6):1 196-1 197.
[6] CHRISTOPH J,BERG T,CHENG J,et al.Intrahepatic cholestasis in common chronic liver diseases[J].European Journal of Clinical Investigation,2013,43(10):1 069-1 083.
[7] CARPENTER D J.St John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning:What is the evidence for clinically relevant benefit?[J].Alternative Medicine Review A Journal of Clinical Therapeutic,2011,16(1):17.
[8] MORELLI V,NAQUIN C,WEAVER V.Alternative therapies for traditional disease states:Osteoarthritis[J].American family physician,2003,67(2):339-344.
[9] 魏晓楠.S-腺苷甲硫氨酸(SAM)在大肠杆菌中的合成[D].福建:集美大学,2014.
[10] KAMARTHAPU V,RAGAMPETA S,RAO K V,et al.Engineered Pichia pastoris for enhanced production of S-adenosylmethionine[J].AMB Express,2013,3(1):40.
[11] RUAN Liying,LI Lu,ZOU Dian,et al.Metabolic engineering of Bacillus amyloliquefaciens for enhanced production of S-adenosylmethionine by coupling of an engineered S-adenosylmethionine pathway and the tricarboxylic acid cycle[J].Biotechnology for Biofuels, 2019,12(1):211
[12] 王杰鹏.发酵法生产S-腺苷蛋氨酸前体蛋氨酸补加策略[J].生物工程学报,2008,24(10):1 824-1 827.
[13] MARKHAM G D,DEPARASIS J,GATMAITAN J.The sequence of metK,the structural gene for S-adenosylmethionine synthetase in Escherichia coli[J].Journal of Biological Chemistry,1985,259(23):14 505-14 507.
[14] 刘珞.高产S-腺苷蛋氨酸合成酶基因工程菌的构建[J].北京化工大学学报(自然科学版),2015,40(2):70-73.
[15] HU Xiaoqing,CHU Ju,ZHANG Siliang,et al.A novel feeding strategy during the production phase for enhancing the enzymatic synthesis of S-adenosyl-L-methionine by methylotrophic Pichia pastoris[J].Enzyme and Microbial Technology,2007,40(4):669-674.
[16] DIPPE M,BRANDT W,ROST H,et al.Rationally engineered variants of S-adenosylmethionine (SAM) synthase:Reduced product inhibition and synthesis of artificial cofactor homologues[J].Chem Commun,2015,51(17):3 637-3 640.
[17] KANAI M,MIZUNUMA M,FUJII T,et al.A genetic method to enhance the accumulation of S-adenosylmethionine in yeast[J].Applied Microbiology and Biotechnology,2017,101(4):1 351-1 357.
[18] DIPPE M, BRRANDT W,ROST H,et. Rationally engineered variants of S-adenosylmethionine (SAM) synthase: Reduced product inhibition and synthesis of artificial cofactor homologues[J].Chemical Communications,2019,51(17):3 637-3 640.
[19] 安胜欣.酿酒酵母S-腺苷甲硫氨酸合成酶基因的克隆及表达研究[D].北京:北京化工大学,2006.
[20] RONG Jingjing,DIAO Zhenyu,ZHOU Guohua.Research progress on E.coli expression system[J].Pharmaceutical Biotechnology,2005.
[21] 吴梧桐.生物制药工艺学(第二版)[M].北京:中国医药科技出版社,2006.
[22] DUAN Xuguo,CHEN Jian,WU Jing.Optimization of pullulanase production in Escherichia coli by regulation of process conditions and supplement with natural osmolytes[J].Bioresour Technol,2013,46(10):79-85.
